To examine this response in vivo, we employed a mouse model of tuberous sclerosis complex involving xenograft tumors derived from the rat TSC2-/- tumor cell line ELT3 (Hodges et al., 2002). The gene discussed is TSC2; the disease is tuberous sclerosis.